Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target

Benzinga · 2d ago
Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $86 price target.